| Biotechnology Industry | Healthcare Sector | Adam Mendelsohn CEO | OTC PINK Exchange | 92854B117 CUSIP |
| US Country | 50 Employees | - Last Dividend | 6 Jan 2020 Last Split | 29 Mar 2017 IPO Date |